Document is current
Any future updates will be listed below
-
Authors
Aydin, Ezra https://orcid.org/0000-0003-4845-053X
Tsompanidis, Alex https://orcid.org/0000-0002-7338-6536
Chaplin, Daren
Hawkes, Rebecca
Allison, Carrie https://orcid.org/0000-0003-2272-2090
Hackett, Gerald
Austin, Topun https://orcid.org/0000-0002-8428-8624
Padaigaitė, Eglė https://orcid.org/0000-0002-5783-727X
Gabis, Lidia V. https://orcid.org/0000-0002-1612-5487
Sucking, John https://orcid.org/0000-0002-5098-1527
Holt, Rosemary https://orcid.org/0000-0002-3650-0977
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
-
Funding
Funding for this research was provided by:
Autism Research Trust
National Institute of Health Research (NIHR) Senior Investigator Award
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Templeton World Charitable Foundation inc
National Institute for Health Research
Wellcome Trust
Medical Research Council
NIHR Brain Injury MedTech Co-operative
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 16 January 2024
First Online: 28 February 2024
Declarations
:
: A favorable ethical opinion for the study’s protocol, recruitment criteria and related materials, including the consent form, was given by the East of England Cambridge Central Research Ethics Committee (REC Ref 16/EE/0004) and the Research and Development Department of Cambridge University Hospitals (CUH).
: SBC is Editor-in-Chief of Molecular Autism.
: Not applicable.
